Retirement Systems of Alabama
CYTK icon

Retirement Systems of Alabama’s Cytokinetics CYTK Stock Holding History

Retirement Systems of Alabama’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
140,426
-9,465
-6% -$680K 0.04% 463
2026
Q1 		$9.88M Buy
149,891
+3,223
+2% +$205K 0.03% 509
2025
Q4 		$9.32M Buy
146,668
+1,996
+1% +$124K 0.03% 525
2025
Q3 		$7.95M Sell
144,672
-1,295
-0.9% -$53.3K 0.03% 570
2025
Q2 		$4.82M Buy
145,967
+2,330
+2% +$81K 0.02% 721
2025
Q1 		$5.77M Buy
143,637
+142
+0.1% +$6.53K 0.02% 655
2024
Q4 		$6.75M Buy
143,495
+565
+0.4% +$29.3K 0.03% 625
2024
Q3 		$7.55M Buy
142,930
+1,414
+1% +$78.8K 0.03% 595
2024
Q2 		$7.67M Buy
141,516
+18,384
+15% +$1.11M 0.03% 563
2024
Q1 		$8.63M Buy
+123,132
New +$9.52M 0.03% 538

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Retirement Systems of Alabama's CYTK Position: Q2 2026 in Review

Retirement Systems of Alabama reduced its Cytokinetics (CYTK) stake by 6.3% in Q2 2026, selling an estimated $680K and leaving 140,426 shares worth $12M. The position accounts for 0.04% of the portfolio, ranked #463.

Retirement Systems of Alabama first reported a position in CYTK in Q1 2024 and has held it in 10 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Retirement Systems of Alabama held 140,426 shares of Cytokinetics worth $12M as of Q2 2026.
  • Retirement Systems of Alabama sold 9,465 Cytokinetics shares in Q2 2026, an estimated $680K.
  • Cytokinetics made up 0.04% of Retirement Systems of Alabama's portfolio in Q2 2026, its #463 holding.
  • Retirement Systems of Alabama first reported a position in Cytokinetics in Q1 2024 and has held it in 10 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Retirement Systems of Alabama's 13F filing for Q2 2026, filed 28 Jul 2026.